About
Licensing & Collaborative Opportunities
Broad-Spectrum Antiviral for Flaviviruses
EEG Brain Function Measurement
Epilepsy or Tumor Resection Surgery using Passive Brain Mapping
IU1 Inhibits Dengue virus replication
Pathogen Detection using a Flexible Substrate Sensor System
Repurposed Pharmaceutical Compositions with Anti-flaviviral Activity
Small Molecule Targeting Gram-Positive Bacteria
Spinal Cord Reflex Neurorehabilitation
By partnering with public and private institutions HRI delivers the resources necessary to translate research findings into products for the prevention, diagnosis and treatment of disease.
HRI has a long and distinguished history of recognizing, protecting and developing novel technologies. Successful transfers include a number of major medical technologies such as the prostate specific antigen (PSA) test, photodynamic cancer therapy, pox virus vectors, a diagnostic assay for HIV tropism, and the blood thinner Angiomax.
